Start-up to develop new treatment for heart failure
Our Department exploits their academic findings towards rational therapy development for genetic and acquired forms of heart failure in the Dutch spin-off company Mirabilis Therapeutics BV that was founded in 2015.
Mirabilis Therapeutics BV is a drug development company dedicated to the discovery and development of innovative products in the field of cardiovascular diseases.
For more information on Mirabilis Therapeutics BV, please visit: www.mirabilis-therapeutics.com
Also read
-
More than another ‘to-do’: how the UTQ helped me rethink my teaching
At Maastricht University, the University Teaching Qualification (UTQ) is a professional development programme designed to strengthen teaching and learning. It supports teachers in developing core teaching competencies through a combination of workshops, peer learning, on-the-job experience, and...
-
Brightlands Circular Space focuses on integrated approach to entire plastic value chain
Construction has officially started today in Limburg of Brightlands Circular Space, a demonstration facility that accelerates the transition to circular plastics.
-
MaaSec – The Netherlands' Only Active ACM Student Chapter captures the flag
In January, a group of Computer Science students at Maastricht University launched MaaSec, currently the only active ACM student chapter in the Netherlands. And in just a few months, they've already made a name for themselves; especially in the world of Capture the Flag (CTF) competitions.
